1 Aug

Sandridge Energy and Baytex Energy

Bison Interests are keen on these two. Highly geared, but benefiting from rising demand. You’ll have to listen to the lastest episode of the Market Huddle to get the detailed thesis. Or search for Josh Young on Seeking Alpha.

House prices, globally …

There are comments.

28 July ‘21

Earnings set to rocket

Analysts’ forecasts for earnings, which are typically for 3-5 years, are more backward looking than forward looking. What goes up like a rocket tends to return to earth quite smartly.

Inflation expectations

Like a lot of people, I tend to think of the …

There are comments.

20 July

Climate change and the class struggle

The poor are different. They have less money. This means that action to combat climate change which results in essentials becoming more expensive hits them hardest. For example:

• heating for houses, often draughty,
• petrol, and diesel for older cars,
• flights to Spain …

There are comments.

19 July 2021

Today has been trailed for weeks as “Freedom Day,” when life in the UK was going to return to normal. Well, it didn’t quite work out that way, as measured cases are still quite high and the badly designed “NHS Covid” app has wreaked havoc by …

There are comments.

Weekend 17/18 July (and week in review)

Revolut

Revolut is the highest value private company in the UK at £33B. It shows all the signs of being prepared for an IPO, through one of the many routes (SPAC, probably). The mainstream press is carrying lots of stories about how …

There are comments.

Wrap

A 10Y and a 3Y auction didn’t run smoothly, with the result that yields are up. This buoyed SPX, and also boosted USD.JPY. It didn’t knock NDX back, but the Nasdaq didn’t rise any more than the SPX, which is unusual. $SPCE, Virgin Galactic had …

There are comments.

Inmune

I am fairly convinced that Alzheimer’s Disease is an auto-immune condition. I am totally convinced that it is the most economically costly disease which is facing the world right now. INmune Bio, Inc. has an FDA approved treatment. The FDA approve drugs based on their not being harmful …

There are comments.

9 July

Market review

I haven’t had time to write daily ‘wraps’ recently. The opening up of the UK economy has had a personal impact on me. I have needed to spend my time working on other things. I will therefore try to make sense of market behaviour over …

There are comments.

6 July

Wrap

The markets got totally spooked by a range of ISM reports today. The services index came in very weak, compared to recent months, which I would have though would have been expected. Labour costs were expected to rise, suggesting that labour shortages were the problem. For me …

There are comments.

Note for 5 July

I was away over the weekend and didn’t look at a screen. Well, maybe my phone a bit, and I read some stuff on my Kindle, but that doesn’t count. Does it?

Wrap

US markets were closed today. Other equity markets were generally flat …

There are comments.